[effects of dupilumab on perennial allergic rhinitis in atopic dermatitis patients].

CONCLUSION: Dupilumab has a therapeutic effect on severe PAR in severe AD patients.
PMID: 33310981 [PubMed - in process]

Source: Arerugi - December 15, 2020 Category: Allergy & Immunology Authors: Yamamoto M, Okuno M, Sasaki T, Fujimoto R, Kataoka Y, Kawashima K Tags: Arerugi Source Type: research